The Overlooked Link Between Perfusion Practice and Cardiac Readmissions

Readmission after cardiac surgery is expensive twice over: the cost of the second episode, and the penalty exposure and public reporting that come with it. Readmission is usually treated as a post-discharge problem. Some of its roots are further upstream — in the operating room.

Where the operating room reaches into week four

Complications that begin intraoperatively — acute kidney injury, wound and other infections associated with transfusion, fluid and hemodilution management — are among the drivers of both prolonged index stays and subsequent readmissions. Perfusion practice influences each of these to a degree that is real, even if it is never the whole story.

The value-based math

Why this belongs in the cost conversation

Treating perfusion purely as a supply line to be minimized misses this entirely. The practices that reduce transfusion and organ injury are also the practices that reduce the complications driving readmission. A perfusion review that looks only at product price, and never at practice, leaves the largest financial lever — the downstream cost of complications — completely untouched.